You are currently viewing a new version of our website. To view the old version click .

Molecular Profiling and Identification of Molecular Signatures Associated with Tissue Development, Tumorigenesis, and Anticancer Agents’ Action

Topic Information

Dear Colleagues,

During tissue development or tumorigenesis, changes in the mechanisms of transcriptional regulation induce molecular reprogramming, leading to differential gene expressions. Molecular profiling, such as transcriptomics and proteomics, has expanded the knowledge of the repertoire of the transcribed genes specifically inherent to either developing or transformed model systems, thereby allowing the identification and classification of sets of molecular signatures. The individuation of single or panels of novel expression markers has provided a broader picture of the numerous and complex aspects associated with the development of body structures and the molecular pathogenesis of diverse malignancies, also aiding in the dissection of the mode of action of anticancer agents and thereby yielding potentially clinically relevant diagnostic and prognostic information. We are pleased to invite you to contribute original research articles and reviews focused on the identification of molecular biomarkers associated with the building of tissue structures or the progression of cancer, which might also unveil novel routes of signal transduction and cell metabolism, including the molecular profilings associated with antitumoral agents. We look forward to receiving your contributions.

Prof. Dr. Claudio Luparello
Dr. Rita Ferreira
Topic Editors

Keywords

  • tissue development
  • carcinogenesis
  • anticancer agents
  • molecular signatures
  • gene signatures
  • epigenetic signatures
  • protein signatures
  • genomics
  • transcriptomics
  • proteomics

Participating Journals

Biology
Open Access
8,566 Articles
Launched in 2012
3.5Impact Factor
7.4CiteScore
17 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Biomedicines
Open Access
15,606 Articles
Launched in 2013
3.9Impact Factor
6.8CiteScore
17 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Cancers
Open Access
34,313 Articles
Launched in 2009
4.4Impact Factor
8.8CiteScore
20 DaysMedian Time to First Decision
Q2Highest JCR Category Ranking
International Journal of Molecular Sciences
Open Access
105,874 Articles
Launched in 2000
4.9Impact Factor
9.0CiteScore
20 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Onco
Open Access
132 Articles
Launched in 2021
-Impact Factor
-CiteScore
21 DaysMedian Time to First Decision
-Highest JCR Category Ranking

Published Papers